Type 2 | Jotup

Labcorp Launches Weight Loss Management Testing Solutions

Retrieved on:

Thursday, March 7, 2024

Liver, Physician, Obesity, Cardiovascular disease, LH, Weight loss, Vitamin, Micronutrient, Stroke, Risk, Bariatric surgery, Type 2 diabetes, Health, Type 2, Clinical trial, CDC, Kaiser Family Foundation, Weight management, Dietary supplement

BURLINGTON, N.C., March 7, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the introduction of its Weight Loss Management portfolio. The new offering features educational resources and convenient testing solutions, equipping individuals and their physicians with baseline and ongoing health indicators to inform treatment options, including lifestyle modifications, Glucagon-like peptide-1 (GLP-1) medications or bariatric surgery.

Key Points:

GLP-1 medications for weight loss and diabetes management are also dramatically changing the weight management landscape.
The Weight Management Tracking Test assesses average blood sugar and lipid levels to monitor metabolic health as an individual progresses along the weight loss journey.
"The introduction of GLP-1s and other weight loss treatments has increased interest from individuals and their doctors seeking solutions for effective weight management.
"Our Weight Loss Management offering simplifies the process of obtaining baseline measurements and tracking health progress to empower informed conversations about weight loss between individuals and their doctors."

Real-World Data Show Abbott's FreeStyle Libre® Systems and GLP-1 Medicines Work Better Together for People with Type 2 Diabetes

Retrieved on:

Wednesday, March 6, 2024

CGM, Blood, Glucose meter, Treatment, Weight loss, Glycated hemoglobin, Food, Conference, Behavior, Type 2 diabetes, ATTD, Type 2, Smartphone, Patient, Insulin, Heart, Continuous glucose monitor, Appetite, Pharmaceutical industry

These findings were presented at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) held in Florence, Italy, on March 6, 2024.

Key Points:

These findings were presented at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) held in Florence, Italy, on March 6, 2024.
GLP-1 medicines – also known as glucagon-like peptide-1 receptor agonist (GLP-1 RA) - are increasingly being prescribed for people with Type 2 diabetes as they provide glycemic benefit and support weight loss.
"While treating my patients, I've observed that when we've added a CGM, like the FreeStyle Libre technology, to their GLP-1 therapy, we see even better glycemic control.
To maximize the benefits of GLP-1 medicines, it's worth considering the combination of a CGM to support people who live with Type 2 diabetes."

Nium Becomes First Global Fintech to Secure Coveted Type 1 Funds Transfer License from Japan's Financial Service Agency

Retrieved on:

Thursday, February 29, 2024

Transfer, Type 1, JFSA, Payment Services Act 2019, Growth, Commerce, Type 2, Money, Financial Services Agency, Bank

SINGAPORE, Feb. 29, 2024 /PRNewswire/ -- Nium, the leader in real-time cross-border payments, announced today that it is the first non-Japanese company to have secured a Type 1 Funds Transfer Service Provider (FTSP) license from the Japanese Financial Services Agency (JFSA). The Type 1 license authorizes Nium to provide a wide range of financial services, including transferring up to 50 million JPY per transaction via Zengin-Net, Japan's local payment clearing rail, to a Japanese beneficiary account.

Key Points:

In 2021, an amendment to Japan's Payment Services Act lifted cross-border transfer caps for Type 1 license holders, to lower the cost of money transfers in and out of the country.
However, since this amendment passed, few companies have been able to meet the high standards for regulatory approval.
Most other non-bank entities, including Money Service Businesses, hold Type 2 licenses, which limits cross border transfers to only 1 million JPY.
This accomplishment aligns with Nium's commitment to redefining global financial services by providing users with unparalleled access to secure and innovative payment solutions.

Nium Becomes First Global Fintech to Secure Coveted Type 1 Funds Transfer License from Japan's Financial Service Agency

Retrieved on:

Thursday, February 29, 2024

Transfer, Type 1, JFSA, Payment Services Act 2019, Growth, Commerce, Type 2, Money, Financial Services Agency, Bank

SINGAPORE, Feb. 28, 2024 /PRNewswire/ -- Nium, the leader in real-time cross-border payments, announced today that it is the first non-Japanese company to have secured a Type 1 Funds Transfer Service Provider (FTSP) license from the Japanese Financial Services Agency (JFSA). The Type 1 license authorizes Nium to provide a wide range of financial services, including transferring up to 50 million JPY per transaction via Zengin-Net, Japan's local payment clearing rail, to a Japanese beneficiary account.

Key Points:

In 2021, an amendment to Japan's Payment Services Act lifted cross-border transfer caps for Type 1 license holders, to lower the cost of money transfers in and out of the country.
However, since this amendment passed, few companies have been able to meet the high standards for regulatory approval.
Most other non-bank entities, including Money Service Businesses, hold Type 2 licenses, which limits cross border transfers to only 1 million JPY.
This accomplishment aligns with Nium's commitment to redefining global financial services by providing users with unparalleled access to secure and innovative payment solutions.

Ochsner Digital Medicine Partners with Humana Healthy Horizons

Retrieved on:

Wednesday, February 28, 2024

Multimedia, Community, Type 2 diabetes, Hypertension, Health, Type 2, Humana, Ochsner Health System, Patient, Medicaid, Partnership, Nursing

NEW ORLEANS, Feb. 28, 2024 /PRNewswire/ -- Ochsner Digital Medicine has partnered with Humana Healthy Horizons to provide digital medicine services to its members.

Key Points:

NEW ORLEANS, Feb. 28, 2024 /PRNewswire/ -- Ochsner Digital Medicine has partnered with Humana Healthy Horizons to provide digital medicine services to its members.
Through this partnership, Ochsner Digital Medicine will offer Humana Healthy Horizons members who have been diagnosed with Hypertension and Type 2 diabetes remote programs designed to manage and control their conditions.
Ochsner Health was among the earliest innovators in remote patient management and is recognized as a leader in digital medicine.
"Through our work with Humana Healthy Horizons, members will receive high-quality care utilizing our digital platforms and expertise.

HealthSnap Closes $25 Million Series B Funding Amidst Continued Triple Digit Growth of Remote Patient Monitoring and Chronic Care Management Platform

Retrieved on:

Wednesday, February 21, 2024

MIAMI, Feb. 21, 2024 /PRNewswire/ -- HealthSnap, a Miami-based Remote Patient Monitoring (RPM) and Chronic Care Management (CCM) solution for healthcare providers, today announced its Series B financing totaling $25 million. The round was led by Sands Capital, with new investments from Comcast Ventures, Acronym Venture Capital, and Florida Opportunity Fund. Existing shareholders, Asclepius Growth Capital, Florida Funders, MacDonald Ventures, and TGH Ventures also participated in the round. Scott Frederick, a Managing Partner at Sands Capital, will join HealthSnap's board of directors.

Key Points:

MIAMI, Feb. 21, 2024 /PRNewswire/ -- HealthSnap , a Miami-based Remote Patient Monitoring (RPM) and Chronic Care Management (CCM) solution for healthcare providers, today announced its Series B financing totaling $25 million.
Existing shareholders, Asclepius Growth Capital, Florida Funders, MacDonald Ventures, and TGH Ventures also participated in the round.
In the last 18 months, HealthSnap has grown exponentially, bolstered by the successful expansion of its market-leading Remote Patient Monitoring (RPM) platform with the addition of a comprehensive Chronic Care Management (CCM) solution.
HealthSnap is actively hiring for care navigator nurse positions, customer success managers, and patient enrollment specialists.

Analytic Partners Achieves ISO 27001 Certification for Information Security Management Systems (ISMS)

Retrieved on:

Wednesday, February 21, 2024

ISO, Merklin, AICPA, Intelligence, ISO 27001, Confidentiality, Computer security, ISMS, Information, Certified Public Accountant, Certification, ISO/IEC, Privacy, American Institute, Type 2, PII, SOC, Risk management

MIAMI, Feb. 21, 2024 /PRNewswire/ -- Analytic Partners, the leader in commercial analytics, today announced it has achieved ISO 27001 (ISO/IEC 27001) certification for the Information Security Management Systems (ISMS) for its entire enterprise including its commercial analytics solution and platform, GPS Enterprise. This adds to Analytic Partners' existing Service Organization Control (SOC) 2 Type II certification, achieving a major milestone for the company.

Key Points:

MIAMI, Feb. 21, 2024 /PRNewswire/ -- Analytic Partners, the leader in commercial analytics, today announced it has achieved ISO 27001 (ISO/IEC 27001) certification for the Information Security Management Systems (ISMS) for its entire enterprise including its commercial analytics solution and platform, GPS Enterprise.
"We are thrilled to have attained the ISO 27001 certification, which reflects our ongoing dedication to safeguarding the information assets of our customers and our organization," said Peter Kutrubis, Head of Technology, Cybersecurity & Compliance at Analytic Partners.
The key benefits of ISO 27001 certification includes:
Enhanced trust and credibility among clients, partners, and stakeholders
In 2020, Analytic Partners achieved SOC 2 Type II certification.
"Achieving ISO 27001 and SOC 2 Type II certifications is testament to Analytic Partners' unwavering commitment to safeguarding data and upholding the highest information security standards," says Maggie Merklin, Chief Client Officer, at Analytic Partners.

Analytic Partners Achieves ISO 27001 Certification for Information Security Management Systems (ISMS)

Retrieved on:

Wednesday, February 21, 2024

MIAMI, Feb. 21, 2024 /PRNewswire/ -- Analytic Partners, the leader in commercial analytics, today announced it has achieved ISO 27001 (ISO/IEC 27001) certification for the Information Security Management Systems (ISMS) for its entire enterprise including its commercial analytics solution and platform, GPS Enterprise. This adds to Analytic Partners' existing Service Organization Control (SOC) 2 Type II certification, achieving a major milestone for the company.

Key Points:

MIAMI, Feb. 21, 2024 /PRNewswire/ -- Analytic Partners, the leader in commercial analytics, today announced it has achieved ISO 27001 (ISO/IEC 27001) certification for the Information Security Management Systems (ISMS) for its entire enterprise including its commercial analytics solution and platform, GPS Enterprise.
"We are thrilled to have attained the ISO 27001 certification, which reflects our ongoing dedication to safeguarding the information assets of our customers and our organization," said Peter Kutrubis, Head of Technology, Cybersecurity & Compliance at Analytic Partners.
The key benefits of ISO 27001 certification includes:
Enhanced trust and credibility among clients, partners, and stakeholders
In 2020, Analytic Partners achieved SOC 2 Type II certification.
"Achieving ISO 27001 and SOC 2 Type II certifications is testament to Analytic Partners' unwavering commitment to safeguarding data and upholding the highest information security standards," says Maggie Merklin, Chief Client Officer, at Analytic Partners.

NetActuate Announces the Launch of Services from a Third Data Center in India

Retrieved on:

Tuesday, February 20, 2024

ISO, Internet Protocol version 4, Anycast, SOC 2, ISO 27001, PCI DSS, NOC, ISO 14001, ISO 45001, ISO 9001, IPv6, SOC 1, Type 2, SOC, PCI, Cryptocurrency

RALEIGH, N.C., Feb. 20, 2024 /PRNewswire-PRWeb/ -- NetActuate, a leading global provider of network and infrastructure services, has just announced the launch of services from a new data center in Chennai, India. This location marks their third data center in India.

Key Points:

NetActuate is thrilled to announce the launch of services from a new data center in Chennai, India, marking their third in the country.
RALEIGH, N.C., Feb. 20, 2024 /PRNewswire-PRWeb/ -- NetActuate, a leading global provider of network and infrastructure services, has just announced the launch of services from a new data center in Chennai, India .
This location marks their third data center in India.
To learn more about NetActuate's services from Chennai, please schedule a call with an engineer by visiting netactuate.com .

Pre-diabetes gets its due: New $1.2 million award aimed at early intervention and treatment

Retrieved on:

Friday, February 9, 2024

SAN ANTONIO, Feb. 9, 2024 /PRNewswire-PRWeb/ -- Is your A1C not quite high enough to be diabetes? It still could be serious.

Key Points:

SAN ANTONIO, Feb. 9, 2024 /PRNewswire-PRWeb/ -- Is your A1C not quite high enough to be diabetes?
Moreover, the number of people with the condition is expected to double by 2030, with prevalence substantially higher in minority populations, including Hispanics.
A combination of lifestyle changes and medication can lead to a long-term prevention of progression to Type 2 diabetes.
"Proactive detection and early intervention of pre-diabetes will significantly decrease the progression of diabetes, with a tremendously positive impact in our community," Solis-Herrera said.